Q2 2026 13F filing
Updated 27 days ago106 disclosed positions worth $766.5M
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | T TEVJF TEVA PHARMACEUTICAL INDS LTD | $47.8M | 1.41M | 6.23% | — |
| 2 | M MLYS MINERALYS THERAPEUTICS INC | $39.7M | 1.47M | 5.17% | — |
| 3 | T TSEM TOWER SEMICONDUCTOR LTD | $28.2M | 108.3K | 3.68% | — |
| 4 | S STT-PG SPDR SERIES TRUST | $23.7M | 150.0K | 3.10% | — |
| 5 | S SNDX SYNDAX PHARMACEUTICALS INC | $22.2M | 1.01M | 2.89% | — |
| 6 | B BIIB BIOGEN INC | $21.6M | 100.0K | 2.82% | — |
| 7 | B BIIB BIOGEN INC | $20.9M | 96.6K | 2.72% | — |
| 8 | R RARE ULTRAGENYX PHARMACEUTICAL IN | $19.6M | 588.5K | 2.56% | — |
| 9 | B BMRN BIOMARIN PHARMACEUTICAL INC | $18.8M | 328.6K | 2.45% | — |
| 10 | C CYTK CYTOKINETICS INC | $18.7M | 220.0K | 2.44% | — |
| 11 | B BBIO BRIDGEBIO PHARMA INC | $18.3M | 245.3K | 2.38% | — |
| 12 | C COGT COGENT BIOSCIENCES INC | $17.8M | 459.3K | 2.32% | — |
| 13 | A ASMLF NOVA LTD | $13.7M | 25.2K | 1.78% | — |
| 14 | I INSM INSMED INC | $12.7M | 118.8K | 1.65% | — |
| 15 | M MAZE MAZE THERAPEUTICS INC | $12.5M | 417.6K | 1.63% | — |
| 16 | A AZN ASTRAZENECA PLC | $11.9M | 62.5K | 1.55% | — |
| 17 | S SNYNF SANOFI SA | $11.5M | 269.5K | 1.50% | — |
| 18 | H HELP CYBIN INC | $10.7M | 1.62M | 1.40% | — |
| 19 | L LLY ELI LILLY & CO | $9.6M | 8.0K | 1.26% | — |
| 20 | M MDGL MADRIGAL PHARMACEUTICALS INC | $9.4M | 17.4K | 1.22% | — |
| 21 | T TRVI TREVI THERAPEUTICS INC | $9.3M | 499.0K | 1.21% | — |
| 22 | A ACAD ACADIA PHARMACEUTICALS INC | $9M | 356.5K | 1.18% | — |
| 23 | C CLDX CELLDEX THERAPEUTICS INC NEW | $9M | 240.9K | 1.17% | — |
| 24 | R RYTM RHYTHM PHARMACEUTICALS INC | $8.9M | 80.4K | 1.16% | — |
| 25 | C CYTK CYTOKINETICS INC | $8.5M | 100.0K | 1.11% | — |
| 26 | O ORIC ORIC PHARMACEUTICALS INC | $8.2M | 753.0K | 1.06% | — |
| 27 | L LRCX LAM RESEARCH CORP | $8M | 18.5K | 1.04% | — |
| 28 | A AMAT APPLIED MATLS INC | $8M | 11.0K | 1.04% | — |
| 29 | T TNGX TANGO THERAPEUTICS INC | $7.9M | 254.3K | 1.04% | — |
| 30 | N NVSEF NOVARTIS AG | $7.8M | 50.0K | 1.02% | — |
| 31 | S SEDG SOLAREDGE TECHNOLOGIES INC | $7.7M | 4.00M | 1.01% | — |
| 32 | V VOR VOR BIOPHARMA INC | $7.7M | 416.4K | 1.00% | — |
| 33 | A ABBV ABBVIE INC | $7.6M | 30.3K | 0.99% | — |
| 34 | M MRK MERCK & CO INC | $7.5M | 58.6K | 0.98% | — |
| 35 | J JNJ JOHNSON & JOHNSON | $7.3M | 28.8K | 0.96% | — |
| 36 | I IDYA IDEAYA BIOSCIENCES INC | $7.3M | 196.4K | 0.95% | — |
| 37 | I IMTX IMMATICS N.V | $7.3M | 720.1K | 0.95% | — |
| 38 | ? N/A NUVECTIS PHARMA INC | $7M | 382.9K | 0.92% | — |
| 39 | P PFE PFIZER INC | $6.9M | 286.0K | 0.90% | — |
| 40 | H HRMY HARMONY BIOSCIENCES HLDGS IN | $6.4M | 176.7K | 0.84% | — |
| 41 | X XENE XENON PHARMACEUTICALS INC | $6.3M | 105.0K | 0.83% | — |
| 42 | ? N/A CLIMB BIO INC | $6.3M | 483.7K | 0.82% | — |
| 43 | Z ZBIO ZENAS BIOPHARMA INC | $5.9M | 230.8K | 0.76% | — |
| 44 | N NONOF NOVO-NORDISK A S | $5.8M | 120.7K | 0.75% | — |
| 45 | E ELVN ENLIVEN THERAPEUTICS INC | $5.7M | 112.8K | 0.75% | — |
| 46 | P PRLD PRELUDE THERAPEUTICS INC | $5.4M | 1.02M | 0.71% | — |
| 47 | G GLAXF GSK PLC | $5.3M | 102.0K | 0.70% | — |
| 48 | F FBRX FORTE BIOSCIENCES INC | $5.3M | 249.7K | 0.69% | — |
| 49 | ? N/A BIOAGE LABS INC | $5.2M | 213.7K | 0.68% | — |
| 50 | S SRRK SCHOLAR ROCK HLDG CORP | $5.2M | 94.3K | 0.68% | — |